Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Molecular Genetics, |
RCV002225237 | SCV002503843 | uncertain significance | Maturity-onset diabetes of the young type 10 | 2020-10-26 | criteria provided, single submitter | clinical testing | This sequence change is predicted to replace proline with histidine at codon 52 of the INS protein (p.(Pro52His)). The proline residue is moderately conserved (100 vertebrates, UCSC), and is located in the insulin B-chain peptide. There is a moderate physicochemical difference between proline and histidine. The variant is absent in a large population cohort (gnomAD v2.1 and v3.0), and has not been reported in the relevant medical literature or databases. Multiple lines of computational evidence predict a deleterious effect for the missense substitution (6/6 algorithms). A different missense change with a larger physicochemical difference (p.Pro52Leu) at the same position has been identified in a case with maturity-onset diabetes of the young, and impairs function in an in vitro functional assay (PMID: 32916194). Based on the classification scheme RMH ACMG Guidelines v1.2.1, this variant is classified as a VARIANT OF UNCERTAIN SIGNIFICANCE. Following criteria are met: PM2, PP3. |